New York Community Bancorp (NYCB) Reports Q4 Earnings: What Key Metrics Have to Say

NYCB

For the quarter ended December 2022, New York Community Bancorp (NYCB - Free Report) reported revenue of $577 million, up 70.7% over the same period last year. EPS came in at $0.25, compared to $0.31 in the year-ago quarter.

The reported revenue compares to the Zacks Consensus Estimate of $410.71 million, representing a surprise of +40.49%. The company delivered an EPS surprise of -7.41%, with the consensus EPS estimate being $0.27.

While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expectations to determine their next course of action, some key metrics always provide a better insight into a company's underlying performance.

As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock's price performance more accurately.

Here is how New York Community Bancorp performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:

  • Net Interest Margin [%]: 2.28% versus the four-analyst average estimate of 2.25%.
  • Total interest earning assets-Average Balance: $66.80 billion compared to the $66.74 billion average estimate based on three analysts.
  • Efficiency ratio: 48.82% versus the three-analyst average estimate of 47.79%.
  • Total non-interest income (loss): $198 million versus the four-analyst average estimate of $75.08 million.
  • Net Interest Income: $379 million versus the four-analyst average estimate of $379.81 million.

View all Key Company Metrics for New York Community Bancorp here>>>

Shares of New York Community Bancorp have returned +12.4% over the past month versus the Zacks S&P 500 composite's +4.8% change. The stock currently has a Zacks Rank #4 (Sell), indicating that it could underperform the broader market in the near term.

Zacks Names "Single Best Pick to Double"

From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.

It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.

This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.

Free: See Our Top Stock and 4 Runners Up >>